Inventor · disambiguated record
Shawn J. Stachel
Also filed as: STACHEL SHAWN · STACHEL SHAWN J
35 granted patents·5 pending applications·220 citations·filing 2001–2024
96Inventor score
Files withMERCK SHARP & DOHME18MERCK & CO INC6MERCK SHARP & DOHME LLC5COBURN CRAIG A2SLOAN KETTERING INST CANCER2
Top patents by PatentIndex Score
40 records- 0195US7109217B2Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2003·Granted Sep 19, 2006·68 cites·10 claims
- 0291US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 0391US7291620B2N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Nov 6, 2007·46 cites·12 claims
- 0487US7348356B2Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2006·Granted Mar 25, 2008·9 cites·10 claims
- 0586US7371853B2Macrocyclic β-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted May 13, 2008·25 cites·13 claims
- 0683US7115651B2Macrocycles and uses thereofSLOAN KETTERING INST CANCER·Filed 2001·Granted Oct 3, 2006·24 cites·42 claims
- 0781US6867305B2Synthesis of epothilones, intermediates thereto and analogues thereofSLOAN KETTERING INST CANCER·Filed 2001·Granted Mar 15, 2005·24 cites·14 claims
- 0880US12331018B2Pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·1 cites·6 claims
- 0980US2025084064A12-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1077US10239849B2Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted Mar 26, 2019·2 cites·13 claims
- 1176US10287293B2Bicyclic heterocyclic compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted May 14, 2019·2 cites·22 claims
- 1274US10160762B26-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 25, 2018·2 cites·17 claims
- 1372US12195445B22-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 14, 2025·0 cites·15 claims
- 1470US9181261B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2013·Granted Nov 10, 2015·2 cites·12 claims
- 1569US9458181B2Cathepsin cysteine protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Oct 4, 2016·1 cites·15 claims
- 1669US8211904B2Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's diseaseCOBURN CRAIG A·Filed 2006·Granted Jul 3, 2012·1 cites·17 claims
- 1769US7329746B2Macrocyclic beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Feb 12, 2008·4 cites·16 claims
- 1865US7550481B2Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Jun 23, 2009·2 cites·21 claims
- 1962US9505739B2Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 29, 2016·0 cites·11 claims
- 2060US9102673B2Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitorsHANNEY BARBARA·Filed 2012·Granted Aug 11, 2015·1 cites·14 claims
- 2155US2024076291A1Modified isoindolinones as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2250US8354545B23,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2008·Granted Jan 15, 2013·0 cites·14 claims
- 2348US8865701B2Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S diseaseLIU KUN·Filed 2010·Granted Oct 21, 2014·0 cites·8 claims
- 2447US9573913B2Cathepsin cysteine protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 21, 2017·0 cites·11 claims
- 2547US8492387B22-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's diseaseHILLS IVORY D·Filed 2009·Granted Jul 23, 2013·0 cites·11 claims
- 2646US8765759B2Monocyclic CGRP receptor antagonistsSELNICK HAROLD G·Filed 2009·Granted Jul 1, 2014·0 cites·12 claims
- 2746US8552023B2Non-amidic linkers with branched termini as CGRP receptor antagonistsWOOD MICHAEL R·Filed 2009·Granted Oct 8, 2013·0 cites·11 claims
- 2844US12344595B22-amino-n-phenyl-nicotinamides as NAV1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 1, 2025·0 cites·15 claims
- 2943US7932275B22-aminopyridine compounds useful as β-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2005·Granted Apr 26, 2011·0 cites·11 claims
- 3042US11655216B2Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted May 23, 2023·0 cites·8 claims
- 3142US7968571B22,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's DiseaseMERCK SHARP & DOHME·Filed 2005·Granted Jun 28, 2011·0 cites·12 claims
- 3241US10174037B2Dihydropyrazolopyrimidinone compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jan 8, 2019·0 cites·19 claims
- 3341US2007203147A12-Aminothiazole Compounds Useful As Aspartyl Protease InhibitorsCOBURN CRAIG A·Filed 2005·Application pending·0 cites
- 3440US10961215B2N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Mar 30, 2021·0 cites·19 claims
- 3539US10894775B2Piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jan 19, 2021·0 cites·12 claims
- 3639US7678783B2Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2005·Granted Mar 16, 2010·0 cites·10 claims
- 3738US2018305332A1Bispiperidinyl Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their UseMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 3837US8394837B22,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's diseaseNANTERMET PHILIPPE G·Filed 2005·Granted Mar 12, 2013·0 cites·14 claims
- 3934US9656990B2Cathepsin cysteine protease inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted May 23, 2017·0 cites·12 claims
- 4032US2002058286A1Synthesis of epothilones, intermediates thereto and analogues thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shawn J. Stachel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →